Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
ANDOVER, Mass., Feb. 9 /PRNewswire-FirstCall/ -- Visage Imaging®, Inc., a wholly owned subsidiary of Pro Medicus Ltd. (ASX:PME), announces today John Danahy joins as General Manager North...
Companies to Provide Advanced Oncology Imaging Solutions for the Clinical and Preclinical Domain MUNICH, Germany, PARSIPPANY, N.J. and ANDOVER, Mass., Dec. 3 /PRNewswire/ -- Definiens, the number...
TORONTO, Aug. 21 /PRNewswire-FirstCall/ -- Predictive medicine company PreMD Inc. (TSX: PMD; Amex: PME) today announced that it has received notice from the American Stock Exchange LLC (the...
TORONTO, Aug. 18 /PRNewswire-FirstCall/ -- Predictive medicine company PreMD Inc. (TSX: PMD - News; Amex: PME - News) today announced that the U.S. Food and Drug Administration ("FDA") has...
- FDA update expected imminently - Successfully completed initial project for Cosmetics company - AMEX appeal continuing TORONTO, Aug. 13 /PRNewswire-FirstCall/ -- Predictive medicine company...
Provides Update on AMEX Appeal Hearing TORONTO, June 20 /PRNewswire-FirstCall/ -- Predictive medicine company PreMD Inc. (TSX: PMD; Amex: PME) today announced the successful completion of its...
Will work together over next 60 days to try to resolve remaining issues TORONTO, June 13 /PRNewswire-FirstCall/ -- Predictive medicine company PreMD Inc. (TSX: PMD; Amex: PME) today announced...
TORONTO, June 4 /PRNewswire-FirstCall/ -- Predictive medicine company PreMD Inc. (TSX: PMD; Amex: PME) today announced that it will appeal the recent decision made by American Stock Exchange...
Company to evaluate appeal options TORONTO, May 30 /PRNewswire-FirstCall/ -- Predictive medicine company PreMD Inc. (TSX: PMD; Amex: PME) today announced it has been notified by the American...
- FDA appeal progressing - Appointment of new board of director - PREPARE data selected as a 'highlighted' poster at American Heart Association Conference on Arteriosclerosis, Thrombosis and...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
